Target intelligence / Profile preview

Ribosomal protein L7 like 1 pseudogene 21 (RPL7L1P21)

Target
RPL7L1P21
Molecular classification
Pseudogene (a non-coding genomic DNA sequence derived from a functional gene[4][5])
01

Overview

RPL7L1 pseudogene 21 (RPL7L1P21) is a processed pseudogene in the human genome, derived from the ancestral ribosomal protein L7-like 1 gene family. As a pseudogene, it does not produce a functional protein, and current genomics databases list it as a non-coding genetic element. Most pseudogenes remain transcriptionally silent or may be transcribed into noncoding RNA, but rarely have significant biological activities. There is no evidence that RPL7L1P21 is involved directly in disease, nor is it targeted by any drugs or used clinically as a biomarker[4][5]. Key summary: RPL7L1P21 is a canonical pseudogene, not a receptor, enzyme, transporter, or other valid therapeutic target; it does not interact with drugs, is not a biomarker, and has no defined disease or biological function. The information provided is accurate with no evident errors based on current genomics resources[4][5].

Other names
Ribosomal protein L7 like 1 pseudogene 21RPL7L1P21
02

Mechanism of action

None (As above, mechanisms of action for drugs do not apply to this pseudogene[5])

03

Biological functions

Other (Pseudogenes are mostly nonfunctional at the protein level; some may have regulatory RNA roles, but RPL7L1P21 has no established molecular or functional role in the literature[4][5])
04

Disease associations

None established (Pseudogenes may rarely be involved in disease through regulatory RNA actions, but there is no direct evidence implicating RPL7L1P21 in any disease[5])

Beyond the preview

Go deeper on Ribosomal protein L7 like 1 pseudogene 21 (RPL7L1P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 like 1 pseudogene 21 (RPL7L1P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call